title: Safety of Propranolol Therapy for Severe Infantile Hemangioma.
authors.affiliation: Service de Dermatologie, CIC P 1401 et Inserm U1035-CHU et Université de Bordeaux, Bordeaux, France.
authors.forename: Sorilla
authors.initials: S
authors.lastname: Prey
authors.affiliation: Laboratoire Pierre Fabre Dermatologie, Lavaur, France.
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Voisard
authors.affiliation: Laboratoire Pierre Fabre Dermatologie, Lavaur, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Delarue
authors.affiliation: Laboratoire Pierre Fabre Dermatologie, Lavaur, France.
authors.forename: Geneviève
authors.initials: G
authors.lastname: Lebbe
authors.affiliation: Service de Dermatologie, CIC P 1401 et Inserm U1035-CHU et Université de Bordeaux, Bordeaux, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Taïeb
authors.affiliation: Service de Dermatologie, CIC P 1401 et Inserm U1035-CHU et Université de Bordeaux, Bordeaux, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Leaute-Labreze
authors.affiliation: Service de Dermatologie, CIC P 1401 et Inserm U1035-CHU et Université de Bordeaux, Bordeaux, France.
authors.forename: Khaled
authors.initials: K
authors.lastname: Ezzedine
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015984:Causality; D002648:Child; D002675:Child, Preschool; D057176:Compassionate Use Trials; D005260:Female; D005602:France; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D056687:Off-Label Use; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D011433:Propranolol